Evidence map›Paper›PMID 40092174›Full record

ArticleOpen veterinary journal2025

Effects of experimental hepatic steatosis on apelin and various biochemical parameters in male white rabbits.

Rana Suhail Al-Juwary, Muntaha Mahmood Al-Kattan

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rana Suhail Al-JuwaryCollege of Education for Girls/Biology, University of Mosul, Mosul, Iraq.
Muntaha Mahmood Al-KattanCollege of Science/Biology, University of Mosul, Mosul, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatic steatosis is the second most prevalent liver disease following viral hepatitis, and its incidence is increasing rapidly, posing a significant threat to human health. Aim: This research aimed to identify natural treatment methods that reduce the risk of experimental hepatic steatosis with triton by answering the following questions:Do polyphenols extracted from strawberries reduce the risk of experimental hepatic steatosis in rabbits?Do omega-3 extracted from almonds reduce the risk of experimental hepatic steatosis in rabbits?Is giving Omega-3, Vit. E considered the optimal treatment for hepatic steatosis? Methods: This study aimed to assess the effects of strawberry polyphenols, omega-3 from almonds, omega-3, and vitamin E on reducing the risk of Triton-induced liver steatosis. The experiment involved 100 male rabbits (10-12 months old, 1,150-1,350 g) divided randomly into the following 10 groups: control group, Triton (300 mg/kg body mass) group, strawberry polyphenols group, strawberry polyphenols with Triton group, almond Omega-3 group, almond Omega-3 with Triton group, strawberry polyphenols with almond Omega-3 group, strawberry polyphenols with almond Omega-3 with Triton group, Omega-3, Vit. E group, and Omega-3, Vit. E with Triton group. Dosing occurred daily for 4 months. Results: The results of the study indicated a significant increase in the levels of Triglycerides, Total cholesterol, Low-density lipoprotein-cholesterol, and Very low-density lipoprotein-cholesterol in the group of rabbits treated with Triton compared with the other groups, while these parameters decreased in the groups treated with strawberry polyphenols, omega-3 from almonds, omega-3, and vitamin E. In addition, the levels of High-density lipoprotein-cholesterol, Paroxinase-1 activity, and apelin concentration decreased in the group treated with Triton but increased in the groups receiving strawberry polyphenols, omega-3 from almonds, omega-3, and vitamin E, at a probability level ( Conclusion: These results suggest that polyphenols extracted from strawberries, Omega-3 extracted from almonds, and Omega-3, Vit. E is a suitable treatment for hepatic steatosis.

Indexed as

Fatty Acids, Omega-3Fatty LiverPolyphenolsAnimalsFragariaMalePolyethylene GlycolsRabbitsVitamin EFatty Acids, Omega-3Polyethylene GlycolsPolyphenolstyloxapolVitamin EAlmondApelinFatty liverPON-1StrawberryTriton

Identifiers

PMID40092174
PMCPMC11910280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.